Olopatadine ophthalmic solution (eye drops) is available as a brand-name drug and as a generic drug. Brand name: Pataday. Olopatadine comes as eye drops and as a nasal spray. Olopatadine eye drops are ...

Learn everything you need to know about Olopatadine-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

Olopatadine (as HCl) 0.6% (665 µg/spray); aqueous nasal spray; contains benzalkonium chloride. Seasonal allergic rhinitis describes an array of symptoms, such as congestion, sneezing, itchy nose, and ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...

Olopatadine (Opat) is an antihistamine, prescribed for symptoms of allergic pink eye (Allergic conjunctivitis). It blocks histamine action, which reduces allergy symptoms. The information provided on ...

According to Nielsen® syndicated data for the latest 52-week period ending May 17, 2025, the Pataday® Once Daily Relief (OTC) market 3 achieved annual sales of approximately $50.0 million*. Commenting ...

Please provide your email address to receive an email when new articles are posted on . Olopatadine hydrochloride 0.2% appears safe for treating mild-to-moderate dry eye in patients with ocular ...

Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products ...

November 19, 2009 (San Diego, California) — Olopatadine hydrochloride nasal spray 0.6% reduces both nasal and ocular symptoms in children younger than 12 years of age with seasonal allergic rhinitis ...

Glenmark has launched Olopatadine Hydrochloride Ophthalmic Solution, 0.1% (OTC). The company said its product compares to the active ingredient found in Pataday2 Twice Daily Relief. Pataday Twice ...